Theriva Biologics, Inc.
8 clinical trials · Sponsor
◉ Watch Theriva Biologics, Inc.
| Record | Firm | Date |
|---|---|---|
| Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020 (NCT05045833) | Theriva Biologics, Inc. | 2021-10-18 |
| Pharmacokinetics, Safety, and Tolerability of SYN-020 (NCT04815993) | Theriva Biologics, Inc. | 2021-03-22 |
| SYN-004 Safety and Tolerability in Allo-HCT Subjects (NCT04692181) | Theriva Biologics, Inc. | 2021-02-15 |
Track Theriva Biologics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.